Elsevier Ireland Ltd.

SHERPA: Unknown

People

  1. Kris
    Kris
  2. Rusch
    Rusch
  3. Ginsberg
    Ginsberg
  4. Riely
    Riely
  5. Travis
    Travis
  6. Drilon
    Drilon
  7. Adusumilli
    Adusumilli
  8. Chaft
    Chaft
  9. Jones
    Jones
  10. Ladanyi
    Ladanyi

Groups

  1. Department of Medicine (86)
  2. Solid Tumor Oncology Division (68)
  3. Thoracic Oncology (58)
  4. Surgery (50)
  5. Survivorship Research (41)
  6. Population Sciences Research Program (38)
  7. GSK Faculty (32)
  8. Psychiatry and Behavioral Sciences, Department of (32)
  9. Department of Pathology and Laboratory Medicine (31)
  10. Epidemiology and Biostatistics (31)
Search Within
Formats
  1. Journal Article (217)
  2. Meeting Abstract (49)
  3. Review (9)
  4. Conference Paper (6)
  5. Editorial (3)
  6. Correspondence (1)
Groups
  1. Department of Medicine (86)
  2. Solid Tumor Oncology Division (68)
  3. Thoracic Oncology (58)
  4. Surgery (50)
  5. Survivorship Research (41)
  6. Population Sciences Research Program (38)

More Groups

People
  1. Mark Kris (30)
  2. Valerie Rusch (19)
  3. Carma Bylund-Lincoln (14)
  4. Michelle Ginsberg (13)
  5. Andreas Rimner (11)
  6. Gregory Riely (11)

More People

Years
  1. 2025 (9)
  2. 2024 (6)
  3. 2023 (16)
  4. 2022 (12)
  5. 2021 (14)
  6. 2020 (12)

More Years

Publications
  1. Lung Cancer (139)
  2. Cancer Letters (65)
  3. Patient Education and Counseling (45)
  4. Computer Methods and Programs in Biomedicine (8)
  5. Molecular and Cellular Endocrinology (6)
  6. Journal of Mens Health (3)

More Publications

Results (285)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Intensity modulated post-operative radiation therapy for locally advanced non-small cell lung cancer
    Meeting Abstract

    Rosenzweig, K.; Gupta, V.; Jackson, A.; Choy, H.; Yorke, E.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • A phase II study of KOS-862 (epothilone D) as second-line therapy in non-small cell lung cancer
    Meeting Abstract

    Rizvi, N.; Villalona-Calero, M.; Lynch, T.; Yee, L.; Gabrail, N.; Sandler, A.; Cropp, G.; Graham, M.; Palmer, G.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • A prospective study to correlate EGFR mutations with gefitinib response in early stage NSCLC
    Meeting Abstract

    Rizvi, N.; Pao, W.; Miller, V.; Rusch, V.; Heelan, R.; Ladanyi, M.; Ginex, P.; Tyson, L.; Zakowski, M.; Kris, M.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Lung adenocarcinomas with mutations in EGFR and KRAS have distinct gene expression profiles
    Meeting Abstract

    Pham, D.; Sarkaria, I.; Socci, N.; Pao, W.; Zakowski, M.; Miller, V.; Kris, M.; Rusch, V.; Singh, B.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Impairment of myocardial contractile reserve following pulmonary lobectomy is biventricular and not improved by a video-assisted thoracic surgery (VATS) approach
    Meeting Abstract

    Park, B.; Markov, N.; Malhotra, J.; Schaefer, U.; Heerdt, P.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Genetic instability, response to DNA damage, and repair capacity in individuals with multiple primary non-small cell lung cancers
    Meeting Abstract

    Orlow, I.; Park, B.; Clas, B.; Mujumdar, U.; Dominguez, G.; Bhingradia, H.; Ginex, P.; Kris, M.; Rusch, V.; Begg, C.; more...
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • A comparison of the antitumour efficacy of ZD6474 and gefitinib (IresSa (TM)) in patients with NSCLC: Results of a randomized, double-blind phase II study
    Meeting Abstract

    Natale, R.; Bodkin, D.; Govindan, R.; Sleckman, B.; Rizvi, N.; Capo, A.; Germonpre, P.; Dimery, I.; Webster, A.; Ranson, M.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • Clinics and epidemiology of hereditary breast cancer
    Meeting Abstract

    Lubinski, J.; Górski, B.; Cybulski, C.; Huzarski, T.; Byrski, T.; Gronwald, J.; Jakubowska, A.; Stawicka, M.; Gozdecka-Grodecka, S.; Szwiec, M.; more...
    Toxicology Letters (2005)

    Fulltext@MSK | Save
  • Gene expression profiling of malignant mesothelioma for prognostic prediction and identification of potential therapeutic targets and differential diagnostic markers
    Meeting Abstract

    Lopez-Rios, F.; Chuai, S.; Hussain, S.; Szoke, J.; Gerald, W.; Zakowski, M.; Olshen, A.; Flores, R.; Rusch, V.; Ladanyi, M.
    Lung Cancer (2005)

    Fulltext@MSK | Save
  • A multicenter phase 2 trial of neo-adjuvant pemetrexed plus cisplatin followed by extrapleural pneumonectomy (EPP) and radiation (RT) for malignant pleural mesothelioma (MPM)
    Meeting Abstract

    Krug, L.; Pass, H.; Rusch, V.; Sugarbaker, D.; Rosenzweig, K.; Friedberg, J.; Bloss, L.; Obasaju, C.; Vogelzang, N.
    Lung Cancer (2005)

    Fulltext@MSK | Save